| 
May 26, 2023
As the trading session draws to a close Green Thumb Industries is ticking higher but remains broadly flat: Green Thumb Industries is currently trading at $7.35 but remains in a $7.15 – $7.37 range.
On the flip side, highly important Core Durable Goods Orders data from United States beat analyst expectations of 0% with a reading of -0.2%. Highly important Pending Home Sales data from United States beat analyst expectations of 0.5% with a reading of 0%.
Meanwhile, United States Core PCE Price Index (MoM) (Apr) released today at 12:30 UTC with a figure of 0.4, while the previous figure was 0.3.
Green Thumb Industries Inc. could be slowing down soon; it is getting close to the resistance line and is now at $7.44, only 9 cents away. Crossing the resistance line could, however, suggest that further gains are ahead. Despite posting gains so far today, Green Thumb Industries slid below its 10 day Simple Moving Average at $7.32 in earlier trade — an early indicator that a negative trend could be emerging.
After posting consistent gains as part of its uptrend and being lifted by intraday sentiment, technical factors suggest Green Thumb Industries is set for a reversal in the coming days.
This rally in Green Thumb Industries's share price coincides with other health care stocks as Astrazeneca PLC is trading at $72.61 after ending yesterday's session at $71.79 (up 1.14%).
At the same time, Medtronic is down 2.47% from the beginning of the session and now trades around $81.48. After closing the previous session (yesterday) at $64.56, Bristol-Myers Squibb Company lost 72 cents and is trading around $63.84.
5 months ago Green Thumb Industries reached a significant high of $15.63 but has consequently lost 53.2% since then.
